Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
05/2001
05/03/2001WO2001030745A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
05/03/2001WO2001030387A1 Preventives or remedies for arrhythmia
05/03/2001WO2001030149A1 Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
05/03/2001WO2000066546A3 Monofluoroalkyl derivatives
05/03/2001CA2388479A1 Preventives or remedies for arrhythmia
05/03/2001CA2388077A1 Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
05/02/2001EP1095936A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
05/02/2001EP1095933A1 Novel N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
05/02/2001EP1095930A1 Novel compounds
05/02/2001EP1095037A1 Improved process of synthesis of 5-methoxy- 2- (4-methoxy- 3,5-dimethyl- 2-pyridyl)methyl]sulfinyl-1h-benzimidazole
05/02/2001EP1095036A1 Cinnamic acid derivatives as cell adhesion molecules
05/02/2001EP1095035A1 Method for preparing 4-(3-pyridinyl)-1h-imidazole and the intermediates used
05/02/2001EP1095020A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
05/02/2001EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
05/02/2001EP1095015A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators
05/02/2001EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
05/02/2001EP1094816A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
05/02/2001EP0988304B1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv)
05/02/2001EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
05/02/2001EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
05/02/2001EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
05/02/2001EP0946097B1 Composition and use
05/02/2001CN1293680A Method for producing aqueous polymer dispersions containing colorants
05/02/2001CN1293672A Process for preparation of nitrofuanidine derivatives
05/02/2001CN1293666A Benzenesulfonamide-derivatives and their use as medicaments
05/02/2001CN1065265C Photo-cross-linkable 1,2-phenylene derivatives
05/02/2001CN1065242C Byridyl-thiazoles
05/01/2001US6225445 Fatty acid derivatives of sulfhydryl-containing compounds (for example, sulfhydryl-containing peptides or proteins) comprising fatty acid-conjugated products with a disulfide linkage
05/01/2001US6225341 For inhibiting neuraminidase; for therapy and prophylaxis of virus infection
05/01/2001US6225329 Useful in the treatment of type i diabetes, type ii diabetes, impaired glucose tolerance, insulin autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases
05/01/2001US6225328 Adamantyl-substituted retinoids and pharmaceutical/cosmetic compositions comprised thereof
05/01/2001US6225323 Activated iododerivatives for the treatment of cancer and AIDS
05/01/2001US6225316 3-phenyl-pyridine-derivatives
05/01/2001US6225311 Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
05/01/2001US6225309 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
05/01/2001US6225305 Substituted urea and isothiorea derivatives as no synthase inhibitors
05/01/2001US6225023 Sulfonamide compound and method for its production, metal chelate compound employing the sulfonamide compound, and optical recording medium employing the metal chelate compound
05/01/2001CA2001265C Analogs of peptidase substrates
04/2001
04/26/2001WO2001029031A1 Process for the preparation of paroxetine
04/26/2001WO2001029004A1 Oxidation process for the preparation of intermediates useful in the synthesis of diarylpyridines
04/26/2001WO2001029003A1 Process for the preparation of 1-(6-methylpyridin-3-yl)-2-(4-methylthiophenyl)-ethanone and its use in the synthesis of diarylpyridines
04/26/2001WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity
04/26/2001WO2000055139A3 Heterocyclic urea and related compounds useful as anti-inflammatory agents
04/26/2001WO2000055125A3 N-cyanomethyl amides as protease inhibitors
04/26/2001US20010000521 Biological activity inhibiting topoisomerase I and/or topoisomerase II; antitumor agents, viricides
04/26/2001US20010000519 Tridentate ligand
04/26/2001CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity
04/25/2001EP1093819A2 Compounds and compositions for delivering active agents
04/25/2001EP1093453A1 Naaladase inhibitors useful as pharmaceutical compounds and compositions
04/25/2001EP1093367A1 Protease inhibitors
04/25/2001CN1292782A Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed ETA/ETB-receptor antagonists
04/25/2001CN1292781A Antivirals
04/25/2001CN1292725A Sonic method of enhancing chemical reactions
04/25/2001CN1292379A Preparation method of pyrazolzo [4,3-d] pyrimidine-7-ketone-3-pyridyl sulfonyl compound and its intermediate
04/24/2001US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde
04/24/2001US6221911 Reducing subcutaneous fat deposits in a subject; improving the skin condition of a subject
04/24/2001US6221887 Treatment of inflammatory disorders with NMDA antagonists and sodium channel antagonists
04/24/2001US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
04/24/2001US6221868 Remedies/preventives for frequent urination/urinary incontinence and tropone derivatives
04/24/2001US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase.
04/24/2001US6221858 Pyridyl-and pyrimidyl-piperazines in the treatment of substance abuse disorders
04/24/2001CA2165192C Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors
04/19/2001WO2001027113A2 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES
04/19/2001WO2001027103A1 Fab i inhibitors
04/19/2001WO2001027096A1 Aminomethyl-(hetero)aryl derivatives and their use as tryptase inhibitors
04/19/2001WO2001027085A1 Nicotinyl aspartyl ketones as inhibitors of caspase-3
04/19/2001WO2001027084A1 Beta disubstituted metalloprotease inhibitors
04/19/2001WO2001027083A1 Process for the preparation of aryl-pyridinyl compounds
04/19/2001WO2001027070A1 Use of carbonylamino derivatives against cns disorders
04/19/2001WO2001027068A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
04/19/2001WO2000073274A3 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
04/19/2001WO1999032448A8 Substituted pyridine and pyridazine compounds and their pharmaceutical use
04/19/2001CA2386485A1 Beta disubstituted metalloprotease inhibitors
04/19/2001CA2386411A1 Nicotinyl aspartyl ketones as inhibitors of caspase-3
04/18/2001EP1092720A2 Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof
04/18/2001EP1091648A1 Biocidal composition and its use
04/18/2001EP1070053A4 Synthesis of 3-amino-2-chloro-4-methylpyridine from acetone and ethyl cyanoacetate
04/18/2001EP0915823B1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
04/18/2001EP0791583B1 Process for producing 3-(aminomethyl)-6-chloropyridines
04/18/2001EP0723544B1 ALKOXY ALKYL CARBAMATES OF IMIDAZO[1,2-a]PYRIDINES
04/18/2001CN1291982A Nitrate salt of anti-ulcer medicine
04/18/2001CN1291979A Novel pyridazine derivatives and drugs containing same as active ingredient
04/18/2001CN1291973A N-sulphonyl and N-sulphinyl phenylglycinamide
04/17/2001US6218543 Involve the processing of nicotinamide reaction crudes over both cation exchange and weak base resins and the subsequent recovery of usp grade nicotinamide by simple evaporation.
04/17/2001US6218539 Phenyl ureas
04/17/2001US6218431 Substituted biphenyls
04/17/2001US6218426 For therapy of mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated
04/17/2001US6218396 Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
04/17/2001US6218393 Anthranilic acid derivatives as multi drug resistance modulators
04/17/2001US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices
04/17/2001CA2158457C Naphthalene derivatives
04/17/2001CA2027765C Mevinic acid derivatives
04/12/2001WO2001025244A1 Complexes of mid-transition metals and unsaturated nitrogenous ligands as single-site catalysts
04/12/2001WO2001025229A1 Amide compounds
04/12/2001WO2001025210A2 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands
04/12/2001WO2001025209A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications
04/12/2001WO2001025208A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
04/12/2001WO2001025207A1 Novel nicotinonitrile compounds
04/12/2001WO2001025206A1 Method for preparing hydroximic compounds for use as fungicides
04/12/2001WO2001025205A1 Novel pyridine derivatives